CSI offers a full menu of both hematopoietic and solid tumor molecular assays for qualitative and quantitative analysis. The use of CSI’s targeted molecular assays yields highly valuable data necessary for precise diagnosis and appropriate therapy selection. More specifically, our molecular testing provides:
- Comprehensive in-house hematopoietic and solid tumor offering
- Customizable reflex panels
- Interpretation guidelines provided
- Enhanced microdissection leads to better sensitivity, fewer QNS
Utilizing the most advanced equipment and technologies available, CSI molecular testing provides actionable, reliable results that assist in guiding personalized, genetic-based treatment options for patients.
Below is a list of our most frequently ordered molecular assays.